Elicio Therapeutics, Inc.
ELTXFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Elicio Therapeutics, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Source: Elicio Therapeutics, Inc. — 10-K filed Mar 17, 2023
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 6 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Feb 3, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| Summit Financial, LLC | 2026-03-31 | 10,010 | Not shown | SEC filing |
| HRT FINANCIAL LP | 2026-03-31 | 21,611 | Not shown | SEC filing |
| NORTHERN TRUST CORP | 2026-03-31 | 59,734 | Not shown | SEC filing |
| Engineers Gate Manager LP | 2026-03-31 | 13,160 | Not shown | SEC filing |
| MOODY LYNN LIEBERSON & WALKER, LLC | 2026-03-31 | 10,000 | Not shown | SEC filing |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2026-03-31 | 30,051 | Not shown | SEC filing |
| XTX Topco Ltd | 2026-03-31 | 13,785 | Not shown | SEC filing |
| HighTower Advisors, LLC | 2026-03-31 | 11,166 | Not shown | SEC filing |
| Quadrature Capital Ltd | 2026-03-31 | 16,912 | Not shown | SEC filing |
| MEYER HANDELMAN CO | 2026-03-31 | 13,899 | Not shown | SEC filing |
| 683 Capital Management, LLC | 2026-03-31 | 56,442 | Not shown | SEC filing |
| BANK OF AMERICA CORP /DE/ | 2026-03-31 | 15,333 | Not shown | SEC filing |
| SBI Securities Co., Ltd. | 2026-03-31 | 82 | Not shown | SEC filing |
| Qube Research & Technologies Ltd | 2026-03-31 | 12,482 | Not shown | SEC filing |
| BNP PARIBAS FINANCIAL MARKETS | 2026-03-31 | 6,344 | Not shown | SEC filing |
| EFG International AG | 2026-03-31 | 2,200 | Not shown | SEC filing |
| Balyasny Asset Management L.P. | 2026-03-31 | 244,814 | Not shown | SEC filing |
| RENAISSANCE TECHNOLOGIES LLC | 2026-03-31 | 121,631 | Not shown | SEC filing |
| Caitong International Asset Management Co., Ltd | 2026-03-31 | 3 | Not shown | SEC filing |
| STATE STREET CORP | 2026-03-31 | 50,620 | Not shown | SEC filing |
- Each value is checked against Elicio Therapeutics, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 20 rows: no share price from within three months of their report dates is on file, so they could not be checked.
Filer report history
Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security.
- ROYAL BANK OF CANADA: 219 shares reported 2025-12-31; 23 shares reported 2026-03-31.
- &PARTNERS: 10,000 shares reported 2025-12-31; 10,000 shares reported 2026-03-31.
- SUSQUEHANNA INTERNATIONAL GROUP, LLP: 64,052 shares reported 2025-12-31; 70,804 shares reported 2026-03-31.
- Farther Finance Advisors, LLC: 705 shares reported 2025-12-31; 721 shares reported 2026-03-31.
- GEODE CAPITAL MANAGEMENT, LLC: 132,518 shares reported 2025-12-31; 135,164 shares reported 2026-03-31.
- MILLENNIUM MANAGEMENT LLC: 22,846 shares reported 2025-09-30; 92,762 shares reported 2026-03-31.
- Knoll Capital Management, LLC: 630,915 shares reported 2025-12-31; 630,915 shares reported 2026-03-31.
- Steward Partners Investment Advisory, LLC: 1,554 shares reported 2025-12-31; 2,023 shares reported 2026-03-31.
- UBS Group AG: 32,016 shares reported 2025-12-31; 33,769 shares reported 2026-03-31.
- OMERS ADMINISTRATION Corp: 23,500 shares reported 2025-12-31; 10,700 shares reported 2026-03-31.
- BlackRock, Inc.: 45,179 shares reported 2025-12-31; 50,597 shares reported 2026-03-31.
- Mayflower Financial Advisors, LLC: 10,000 shares reported 2025-12-31; 10,000 shares reported 2026-03-31.
Showing the 12 most recent filer reports.
22 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Elicio Therapeutics, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2023-12-22 · Chudnovsky Yekaterina: Larger than all 12 other insider purchases of Common Stock on file. SEC filing
- 2021-12-28 · Venkatesan Jay: Larger than 11 of the 12 other insider purchases of Common Stock on file. SEC filing
Independent insiders buying near the same time
- 2022-05-19–2022-05-25: 5 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing )
- 2021-12-15–2021-12-20: 5 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing )
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2024-08-12 | Chudnovsky Yekaterina · Director, 10% owner | Convertible Note (convertible into Common Stock) | P — Open market or private purchase | +3,442,341 | 5.81 | SEC filing |
| 2024-06-28 | Chudnovsky Yekaterina · Director, 10% owner | Common Warrants | P — Open market or private purchase | +1,600,000 | 0.00 | SEC filing |
| 2024-06-28 (amended) | Venkatesan Jay · Director | Pre-Funded Warrants | P — Open market or private purchase | +50,000 | 4.99 | SEC filing |
| 2024-06-28 | Venkatesan Jay · Director | Common Warrants | P — Open market or private purchase | +50,000 | 0.00 | SEC filing |
| 2024-06-28 | Venkatesan Jay · Director | Pre-Funded Warrants | P — Open market or private purchase | +50,000 | 4.99 | SEC filing |
| 2024-06-28 (amended) | Venkatesan Jay · Director | Common Warrants | P — Open market or private purchase | +50,000 | 0.00 | SEC filing |
| 2024-06-28 | Chudnovsky Yekaterina · Director, 10% owner | Pre-Funded Warrants | P — Open market or private purchase | +1,600,000 | 4.99 | SEC filing |
| 2024-03-19 | Chudnovsky Yekaterina · Director, 10% owner | Pre-Funded Common Stock Purchase Warrant | P — Open market or private purchase | +1,032,702 | 5.81 | SEC filing |
Showing 8 of 20 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-02-02 | Connelly Robert · CEO, President and Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +147,200 | SEC filing |
| 2026-02-02 | DeMuth Peter · Chief Scientific Officer | Common Stock | A — Grant, award, or other acquisition | +20,800 | SEC filing |
| 2026-02-02 | Shah Preetam · See Remarks | Common Stock | A — Grant, award, or other acquisition | +24,000 | SEC filing |
| 2026-02-02 | Haqq Christopher · See Remarks | Common Stock | A — Grant, award, or other acquisition | +25,400 | SEC filing |
| 2026-02-02 | Connelly Robert · CEO, President and Director | Common Stock | A — Grant, award, or other acquisition | +73,600 | SEC filing |
| 2026-02-02 | DeMuth Peter · Chief Scientific Officer | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +41,600 | SEC filing |
| 2026-02-02 | Shah Preetam · See Remarks | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +47,900 | SEC filing |
| 2026-02-02 | Haqq Christopher · See Remarks | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +50,900 | SEC filing |
Showing 8 of 25 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2021-08-31 | EISA-ABC LLC · 10% owner | Common Stock | J — Other acquisition or disposition | −913,659 | SEC filing |
Showing 1 of 1 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.